Metropolis Healthcare Limited Incorporated in 1980, Mumbai based is a chain of diagnostic companies. It has 106 clinical laboratories 1130 collection centres in seven countries. In India, it has laboratories across 18 states and 173 cities for monitoring of disease, early detection, and diagnostic screening.
The company also provides analytical and support services for the clinical research projects to some clinical research organizations. In the last financial year (2018), approximately 7.7 million patients visited the lab and around 16.0 million tests conducted in the clinics.
Metropolis offers 3,480 clinical laboratory tests and 524 profiles which combines a variety of tests for the specific disease. To provide better services, it has implemented a ‘hub and spoke’ model. Outside India, the company has a presence in Ghana, Zambia, Kenya, Sri Lanka and Mauritius for laboratory operations and in UAE, Nepal, Nigeria, and Oman for 3rd party services.
It has been recognized by Biotrains for “excellence in customer service and delivery” and FICCI for “service excellence (diagnostic center)” and LH Insights for “best in health and fitness” in 2018.
The competitive strengths of the company are:
- Well positioned for expected industry growth
- Widespread operational network
- Comprehensive test menu
- Focus on quality and customer service
- Robust information technology structure
Metropolis IPO Details
| Issue Type | Book Built Issue IPO |
| Face Value | ₹2 per equity share |
| IPO Price | ₹877 to ₹880 per equity share |
| Market Lot | 17 Shares |
| Min Order Quantity | 17 Shares |
| Listing At | BSE, NSE |
| BSE Script Code | 542650 |
| NSE Symbol | METROPOLIS |
| ISIN | INE112L01020 |
| Issue Size | Aggregating up to ₹1,204.29 Cr |
Metropolis IPO Tentative Timetable
| PARTICULAR | DATE |
| IPO Open Date | 3-Apr-19 |
| IPO Close Date | 5-Apr-19 |
| Basis of Allotment Date | 10-Apr-19 |
| IPO Listing Date | 15-Apr-19 |
Metropolis IPO Lot Size
| Application | Lots | Shares | Amount (Cut-off) |
| Minimum | 1 | 17 | ₹14,960 |
| Maximum | 13 | 221 | ₹194,480 |
Registrar & Company Details
Please Click Hare To Check IPO Allotment Status For Metropolis Healthcare Limited
Company Financials:
| PARTICULAR | 31-Dec-18 | 31-Mar-18 | 31-Mar-17 | 31-Mar-16 |
| Total Assets | 5,838.75 | 5,303.40 | 5,151.59 | 3,959.16 |
| Total Revenue | 5,593.06 | 6,435.67 | 5,447.24 | 4,754.69 |
| Profit After Tax | 887.71 | 1,097.47 | 1,072.57 | 819.55 |
Company Promoters:
Promoters of the company are:
- Dr Sushil Kanubhai Shah
- Ameera Sushil Shah
- Metz Advisory LLP
Registrar & Company Delails
| Company Contact Information | Metropolis IPO Registrar |
| Metropolis Healthcare Limited 250 D Udyog Bhavan, Hind Cycle Marg, Worli Mumbai 400 030, Maharashtra Phone: (91 22) 6258 2810 Email: investor.relations@metropolisindia.com Website: https://www.metropolisindia.com/ | Link Intime India Private Ltd Link Intime India Private Ltd C 101, 247 Park, L.B.S.Marg, Vikhroli (West), Mumbai – 400083 Phone: +91-22-4918 6270 Email: metropolis.ipo@linkintime.co.in Website: http://www.linkintime.co.in |
